MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12885-025-13666-3

Медицинская библиотека · BMC cancer · 2025

Experimental study of iodine-131 labeling of a novel tumor-targeting peptide, TFMP-Y4, in the treatment of hepatocellular carcinoma with internal irradiation.

Du Juan, Ren Weiwei, Liu Wenjie, Zhou Yixuan, Li Yushan, Lai Qingyi, Liu Xiongying, Chen Tongsheng, Liu Wenjuan, Chen Zhuanming, Zhang Jinhe, Zhang Peipei, Yuan Jianwei

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To explore and compare the value of 131I-TFMP-Y4 and 131I-Caerin 1.1 in internal irradiation therapy for hepatocellular carcinoma.

METHODS

(1) 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) analysis revealed the inhibitory effects of Caerin 1.1 and TFMP-Y4 on Hepg2 and LO2 cell growth. (2) The chloramine-T method was used to prepare 131I-Caerin 1.1 and 131I-TFMP-Y4. (3) Uptake and elution assays revealed that Hepg2 cells bound and retained 131I-Caerin 1.1 and 131I-TFMP-Y4, and the inhibitory effects on Hepg2 cells were verified with cellular proliferation/toxicity assays. (4) A hormonal nude mouse model was established to study the in vivo therapeutic effects of the peptides alone, 131I-Caerin 1.1 and 131I-TFMP-Y4.

RESULTS

(1) Caerin 1.1 inhibited Hepg2 and LO2 cell proliferation in a concentration-dependent manner, and the half-maximal inhibitory concentrations (IC50) were 9.34 µg/mL and 22.16 µg/mL, respectively. Moreover, TFMP-Y4 did not inhibit these two cell lines. (2) The labeling rates of 131I-Caerin 1.1 and 131I-TFMP-Y4 were high and stable. Both could significantly reduce the activity of Hepg2 cells and inhibit tumor growth in vitro and in vivo.

CONCLUSION

131I-Caerin 1.1 and 131I-TFMP-Y4 significantly inhibited the proliferation of Hepg2 cells in vitro and in vivo. In addition, 131I-TFMP-Y4 can reduce adverse reactions during treatment.

Для цитирования: Du Juan, Ren Weiwei, Liu Wenjie, Zhou Yixuan, Li Yushan, Lai Qingyi, Liu Xiongying, Chen Tongsheng, Liu Wenjuan, Chen Zhuanming, Zhang Jinhe, Zhang Peipei, Yuan Jianwei. Experimental study of iodine-131 labeling of a novel tumor-targeting peptide, TFMP-Y4, in the treatment of hepatocellular carcinoma with internal irradiation.. BMC cancer. 2025. DOI: 10.1186/s12885-025-13666-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.